Experts View about Malaria vaccine Mosquirix : According to the World Health Organization (WHO), one crore five million people in India suffer from malaria in a year. Out of these, 19-20 thousand people die prematurely. Now on October 6, after the approval of the WHO for the malaria vaccine, Mosquirix, there is hope of stopping the disease. Experts say that this vaccine can prove to be a milestone for developing countries like India. In the article of Dainik Jagran newspaper, Dr. Radhakrishna Ramchandani, Associate Professor of AIIMS, Raipur has told that what will be the effect of this vaccine in India? He says that this vaccine, which is administered to children under the age of five, will reduce the country’s major problem to a great extent in the coming time by reducing the mortality rate in deadly malaria by 30 percent.
According to Dr. Radhakrishna, Malaria causes maximum death of children. He says that if we do a class-wise analysis of malaria deaths, we find that about 67 percent of children have a mortality rate. Children below 5 years of age are more among the dead.
Why the impact on children
Malaria parasites have a greater effect in young children. The reason for the greater impact of this disease in children is that children do not come in first contact with the parasite. In the body of children, immunity is not formed at that level as compared to adults. Due to which this disease becomes fatal for children suffering from malaria for the first time.
Which areas in India are affected by malaria the most?
Answering this question, Dr. Radhakrishna says that although malaria occurs in every area of India, but especially in small mountainous areas, forest areas, this disease is more spread. This disease is found more in the eastern and central part of the country, in which the states of North East and Chhattisgarh, Odisha and Jharkhand are prominent.
This parasite spreads malaria
A parasite named Plasmodium enters the body through a mosquito bite and causes malaria. These parasites are of four types, of the Plasmodium found in India and many parts of the world, falciparum is fatal.
How does malaria take its deadly form?
When this parasite enters the body after a mosquito bite, it rapidly increases its offspring and first affects the liver, then destroys the red blood cells of the body. Due to this there is a lack of blood in the body and the dead blood cells i.e. dead blood cells inactivate various parts of the body. In this situation the infected dies.
This is how malaria vaccine will work
The scientific name of this malaria vaccine is RTS, S/S01. When the liver is infected by the bite of a parasitic mosquito, the parasite lineage is not able to multiply due to the resistance to this vaccine. It is the world’s first vaccine developed against not only malaria, but also a parasitic disease. After the approval of WHO on 6 October 2021, its third phase trial has been started. According to research, this vaccine has proved effective in protecting 30 people from fatal malaria.
Why was there a delay in making the vaccine?
According to Dr. Radhakrishna, malaria parasites live in both mosquitoes and humans, due to which the process of making the vaccine became very difficult. After almost 30 years, the current form of the vaccine has brought a ray of hope. Due to the life circle of the parasite, its changing nature, complications in the body’s immunity, there was a delay in the arrival of the vaccine. According to the contract of Bharat Biotech Company with the vaccine maker Glaxo, by 2029, Bharat Biotech will be the main distributor company in the world.